These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 2930579)
41. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo. Majumder S; Dutta P; Mookerjee A; Choudhuri SK Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015 [TBL] [Abstract][Full Text] [Related]
42. Development and characterization of a melphalan-resistant human multiple myeloma cell line. Bellamy WT; Dalton WS; Gleason MC; Grogan TM; Trent JM Cancer Res; 1991 Feb; 51(3):995-1002. PubMed ID: 1988143 [TBL] [Abstract][Full Text] [Related]
43. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors. Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155 [TBL] [Abstract][Full Text] [Related]
44. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells. Chen G; Waxman DJ Biochem Pharmacol; 1994 Mar; 47(6):1079-87. PubMed ID: 8147907 [TBL] [Abstract][Full Text] [Related]
45. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells. Lai SL; Hwang J; Perng RP; Whang-Peng J Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042 [TBL] [Abstract][Full Text] [Related]
46. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells. Oguchi H; Kikkawa F; Kojima M; Maeda O; Mizuno K; Suganuma N; Kawai M; Tomoda Y Anticancer Res; 1994; 14(1A):193-200. PubMed ID: 7909418 [TBL] [Abstract][Full Text] [Related]
47. N-acetylcysteine enhances multidrug resistance-associated protein 1 mediated doxorubicin resistance. Akan I; Akan S; Akca H; Savas B; Ozben T Eur J Clin Invest; 2004 Oct; 34(10):683-9. PubMed ID: 15473893 [TBL] [Abstract][Full Text] [Related]
48. Development and characterization of hydrogen peroxide-resistant Chinese hamster ovary (CHO) cell variants--II. Relationships between non-protein sulfhydryl levels and the induction/stability of the oxidant-resistant phenotype. Cantoni O; Sestili P; Guidarelli A; Cattabeni F Biochem Pharmacol; 1994 Mar; 47(7):1258-61. PubMed ID: 8161355 [TBL] [Abstract][Full Text] [Related]
49. Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents. Townsend AJ; Tu CP; Cowan KH Mol Pharmacol; 1992 Feb; 41(2):230-6. PubMed ID: 1538704 [TBL] [Abstract][Full Text] [Related]
50. Glutathione S-transferase does not play a role in multidrug resistance of L1210/VCR cell line. Bohácová V; Kvackajová J; Barancík M; Drobná Z; Breier A Physiol Res; 2000; 49(4):447-53. PubMed ID: 11072805 [TBL] [Abstract][Full Text] [Related]
51. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery. Bertsche U; Schorn H Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339 [TBL] [Abstract][Full Text] [Related]
52. Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration. Bellamy WT; Dorr RT; Dalton WS; Alberts DS Cancer Res; 1988 Nov; 48(22):6360-4. PubMed ID: 3180055 [TBL] [Abstract][Full Text] [Related]
53. Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody. Tong AW; Lee J; Wang RM; Dalton WS; Tsuruo T; Fay JW; Stone MJ Cancer Res; 1989 Sep; 49(17):4829-34. PubMed ID: 2569359 [TBL] [Abstract][Full Text] [Related]
54. Glutathione as a determinant of cellular response to doxorubicin. Lee FY; Vessey AR; Siemann DW NCI Monogr; 1988; (6):211-5. PubMed ID: 3352767 [TBL] [Abstract][Full Text] [Related]
55. Thiol manipulation as a means of overcoming drug resistance in a novel cyclophosphamide-induced resistant cell line. Richardson ME; Siemann DW Int J Radiat Oncol Biol Phys; 1992; 22(4):781-4. PubMed ID: 1544852 [TBL] [Abstract][Full Text] [Related]
56. Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells. Yang CH; Kuo ML; Chen JC; Chen YC Br J Cancer; 1999 Nov; 81(5):796-9. PubMed ID: 10555748 [TBL] [Abstract][Full Text] [Related]
57. The pulmonary effects of buthionine sulfoximine treatment and glutathione depletion in rats. Coursin DB; Cihla HP Am Rev Respir Dis; 1988 Dec; 138(6):1471-9. PubMed ID: 3202501 [TBL] [Abstract][Full Text] [Related]
58. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Zaman GJ; Lankelma J; van Tellingen O; Beijnen J; Dekker H; Paulusma C; Oude Elferink RP; Baas F; Borst P Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7690-4. PubMed ID: 7644478 [TBL] [Abstract][Full Text] [Related]
59. Relationship between cytocidal activity and glutathione-S-transferase inhibition using doxorubicin coupled to stereoisomers of glutathione with different substrate specificity. Hashizume Y; Asakura T; Oikawa T; Yamauchi T; Soda K; Ohkawa K Anticancer Drugs; 2001 Jul; 12(6):549-54. PubMed ID: 11460002 [TBL] [Abstract][Full Text] [Related]
60. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Meijer C; Mulder NH; Hospers GA; Uges DR; de Vries EG Br J Cancer; 1990 Jul; 62(1):72-7. PubMed ID: 2390486 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]